LGVT · Longevity Diversified Holdings, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-K filed Sep 15, 2026
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on Jul 2, 2026; bars on opposite sides are not compared.
The closing range begins at the captured split on Jul 2, 2026.
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
LGVT
this stock
Longevity Diversified Holdings, Inc.
|
$14.22M | — | — | — | — |
|
VYLR
Vylor Inc.
|
$48.31B | — | — | — | — |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$648.15M | +2.9% | — | — | 0.2% |
|
EVAC
EQV Ventures Acquisition Corp. II
|
$603.18M | +2.9% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
Raw-price comparisons begin at the captured split on Jul 2, 2026; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LGVT | -37.5% | +0.0% | — | -6.0% | — |
| SPY | +1.9% | +1.9% | +10.8% | +1.9% | +14.0% |
| vs SPY | -39.4% | -1.9% | — | -7.9% | — |